Showing results (361-370 of 6,708) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|January 27, 2017
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-SrcXiaomeng Zhang, Yongxi Song, Na Song, et al.Oncotargets and Therapy|January 27, 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myelomaKalyan Nadiminti, Kamal Kant Singh Abbi, Sarah L Mott, et al.Oncotargets and Therapy|February 1, 2017
Clinical outcomes of patients with metachronous second primary lung adenocarcinomasHeng Zhao, Haitang Yang, Ke Han, et al.Oncotargets and Therapy|February 23, 2017
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemiaHenriette Huber, Simone Edenhofer, Sven Estenfelder, et al.Oncotargets and Therapy|February 23, 2017
miR182 activates the Ras-MEK-ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1Jinhui Wang, Wei Wang, Jichen Li, et al.Oncotargets and Therapy|February 23, 2017
Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese populationZhuorong Zhang, Ruizhong Zhang, Jinhong Zhu, et al.Oncotargets and Therapy|March 1, 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new dataGelareh Eslamian, Caroline Wilson, Robin J YoungOncotargets and Therapy|March 1, 2017
Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinomaXiaofeng Yao, Shanshan Sun, Xuan Zhou, et al.Oncotargets and Therapy|March 1, 2017
AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathwayJianjun Chen, Zhenjun Wang, Sanshui YuOncotargets and Therapy|March 1, 2017
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case seriesHonghong Zhang, Fangfang Chen, Zhiqiang Wang, et al.Pageof 671